1Liang W M,Chen J J,Chang C H,et al. An empirical comparison of the WHOQOL-BREF and the SGRQ among patients with COPD [J]. Qual Life Res,2008,17(3):793 -800.
2Pelaia G, Vatrella A, Cuda G, et al. Molecular mechanisms of costeroid actions in chronic inflammatory airway diseases[ J]. Life Sci, 2003,72 (14) : 1549 - 61.
3Podstawka A, Mosiewicz J, Myslinski W. Contemporary opinions on administration of inhaled glucocorticosteroids in the treatment of chronic obstructive pulmonary disease[ J]. Ann Univ Mariae Curie Sklodowska,2004,59 (2) :491 - 7.
4Gartlehner G, Hansen R A, Carson S S, et al. Efficacy and safety of inhaled corticosteroids in patients with COPD : a systematic review and meta-analysis of health outcomes [ J ]. Ann Fam Med, 2006,4 (3) :253 -62.
5Nannini L, Cares C, Lasserson T, et al. Combined corticosteroid and long acting beta-agonist in one inhaler for chronic obstructive pul- monary disease [ J ]. Cochrane Database Syst Rev, 2004,17 ( 3 ) : CD003794.
6Decramer M, Ferguson G. Clinical safety of long-acting beta2-agonist and inhaled cortisterroid combination therapy in COPD [ J ]. COPD,2006,3(3) :163 -71.
